# Human Immunity Against Staphylococcus Aureus Skin Infection

> **NCT02262819** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 49 (actual)

## Conditions studied

- Staphylococcus Aureus Skin Infection

## Interventions

- **DRUG:** S. aureus

## Key facts

- **NCT ID:** NCT02262819
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-10
- **Primary completion:** 2019-04-24
- **Final completion:** 2019-04-24
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2021-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02262819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02262819, "Human Immunity Against Staphylococcus Aureus Skin Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02262819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*